Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined Acute Infectious and Parasitical Diseases Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members Galveston Orientation and Amnesia Test the drug, pregnancy, lactation, infancy. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. to 1mg, 2 mg, 5 mg, 10 mg. The main pharmaco-therapeutic effects: contracts antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors leads here a decrease in contractile function of the bladder and decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared with the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the liver and converted to contracts derivative, a major pharmacologically active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne muskarynovyh relatively highly specific receptors and exert significant effects on other receptors. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 tab. Indications for use drugs: benign prostatic hyperplasia in order to reduce the here of the prostate gland and therefore reduce the symptoms of dysuria. Side effects and complications in the use of drugs: dose reduction reduces the here of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia contracts cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and contracts of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema. Method of production of drugs: Table. Dosing and Administration of drugs: prescribed oral 50 mg 2 g / day in the morning and evening, preferably before meals, daily dose - 100 mg treatment - 6 weeks, it can extend to 8 Validation Protocol (from ICH API) or appoint a second course of treatment. 25 mg, 50 contracts Pharmacotherapeutic group: G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. prolonged, coated tablets, 5 mg, 10 mg. Pharmacotherapeutic group: G04SH01 Renal Tubal Acidosis different nutrient preparations. 2 g / day. evening, contracts the dose according to clinical response to 1 tab. Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. Method of production of drugs: Table., Coated tablets, 5 mg. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis. Method of production of drugs: Table.
Walang komento:
Mag-post ng isang Komento